Xtant Medical Holdings
XTNT
4 hedge funds and large institutions have $3.81M invested in Xtant Medical Holdings in 2015 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
17% less capital invested
Capital invested by funds: $4.61M → $3.81M (-$798K)
33% less funds holding
Funds holding: 6 → 4 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Goldman Capital Management
New York
|
+$81.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
Bard Associates
Chicago,
Illinois
|
-$544K |
| 2 |
TYCC
Texas Yale Capital Corp
St. Petersburg,
Florida
|
-$35K |
| 3 |
OA
Outfitter Advisors
Mclean,
Virginia
|
-$24.9K |
XTNT Hedge Fund Activity: Q3 2015 in Review
4 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q3 2015, worth a combined $3.81M — down 17% from $4.61M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of XTNT and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Goldman Capital Management, adding an estimated $81.8K. The largest seller was Bard Associates, exiting entirely with an estimated $544K sold.
- 4 institutional investors held Xtant Medical Holdings (XTNT) as of Q3 2015, down from 6 in Q2 2015.
- Funds reported $3.81M of Xtant Medical Holdings stock for Q3 2015, down 17% quarter-over-quarter.
- 0 funds opened new Xtant Medical Holdings positions in Q3 2015 and 2 closed out, a net change of -2 holders.
- The largest Xtant Medical Holdings buyer in Q3 2015 was Goldman Capital Management, an estimated $81.8K added.
- The largest Xtant Medical Holdings seller in Q3 2015 was Bard Associates, an estimated $544K sold.
Based on aggregated 13F filings for Q3 2015.